Meyka AI API is live for developers.Start building.
Advertisement
Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Overview

Explore Amphastar Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMPH●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$21.78
$0.74(3.52%)
U.S. Market opens in 54h 50m
Advertisement

Amphastar Pharmaceuticals, Inc. (AMPH)

Meyka AI Score

Z

Key Financials

Market Cap960.3M
P/E Ratio12.54
EPS (TTM)$2.93
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$15.97
3 Months$32.72
1 Year Target$12.56

AMPH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amphastar Pharmaceuticals, Inc. (AMPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.55, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.54 and a market capitalization of 960.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.52%
5-Day Change
15.85%
1-Month Change
15.79%
3-Month Change
11.52%
6-Month Change
-19.69%
Year-to-Date (YTD) Change
-18.67%
1-Year Change
-6.04%
3-Year Change
-60.61%
5-Year Change
4.91%
All-Time (Max) Change
148.91%

Contact Information

https://www.amphastar.com
909 980 9484
11570 6th Street, Rancho Cucamonga, CA, 91730

Company Facts

20,280 Employees
IPO DateJun 25, 2014
CountryUS
Actively Trading

Frequently Asked Questions